Terms: = Brain cancer AND BRD4, O60885, 23476, ENSG00000141867, HUNKI, CAP, MCAP AND Treatment
83 results:
1. Human Epidermal Growth Factor Receptor 2-Low Breast cancer brain Metastases: An Opportunity for Targeted Systemic Therapies in a High-Need Patient Population.
Chehade R; Nofech-Mozes S; Plotkin A; Fan KY; Das S; Sahgal A; Moravan V; Jerzak KJ
JCO Precis Oncol; 2024 Mar; 8():e2300487. PubMed ID: 38547418
[TBL] [Abstract] [Full Text] [Related]
2. MZ1, a brd4 inhibitor, exerted its anti-cancer effects by suppressing SDC1 in glioblastoma.
Li G; Ma L; Feng C; Yin H; Bao J; Wu D; Zhang Z; Li X; Li Z; Yang C; Wang H; Fang F; Hu X; Li M; Xu L; Xu Y; Liang H; Yang T; Wang J; Pan J
BMC Cancer; 2024 Feb; 24(1):220. PubMed ID: 38365636
[TBL] [Abstract] [Full Text] [Related]
3. Cold atmospheric plasma (cap) treatment increased reactive oxygen and nitrogen species (RONS) levels in tumor samples obtained from patients with low-grade glioma.
Aggarwal Y; Vaid A; Visani A; Rane R; Joseph A; Mukherjee S; Tripathi M; Chandra PS; Doddamani R; Dixit AB; Banerjee J
Biomed Phys Eng Express; 2024 Jan; 10(2):. PubMed ID: 38241730
[TBL] [Abstract] [Full Text] [Related]
4. Epidermal growth factor potentiates EGFR(Y992/1173)-mediated therapeutic response of triple negative breast cancer cells to cold atmospheric plasma-activated medium.
Wang P; Zhou R; Zhou R; Feng S; Zhao L; Li W; Lin J; Rajapakse A; Lee CH; Furnari FB; Burgess AW; Gunter JH; Liu G; Ostrikov KK; Richard DJ; Simpson F; Dai X; Thompson EW
Redox Biol; 2024 Feb; 69():102976. PubMed ID: 38052106
[TBL] [Abstract] [Full Text] [Related]
5. Novel Systemic Approaches for the Management of Meningiomas: Immunotherapy and Targeted Therapies.
Ijad N; Dahal A; Kim AE; Wakimoto H; Juratli TA; Brastianos PK
Neurosurg Clin N Am; 2023 Jul; 34(3):447-454. PubMed ID: 37210133
[TBL] [Abstract] [Full Text] [Related]
6. brd4: New hope in the battle against glioblastoma.
Duan W; Yu M; Chen J
Pharmacol Res; 2023 May; 191():106767. PubMed ID: 37061146
[TBL] [Abstract] [Full Text] [Related]
7. A new IRES-mediated truncated Cx32 isoform inhibits global mRNA translation to suppress glioblastoma.
Cai S; Peng F; Tang H; Zhou L; Chen Z; Wu P; Ou Y; Tao L; Wang Q
Biomed Pharmacother; 2023 May; 161():114513. PubMed ID: 36931032
[TBL] [Abstract] [Full Text] [Related]
8. Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line treatment for Advanced Nonsquamous NSCLC With brain Metastases (cap-brain): A Multicenter, Open-Label, Single-Arm, Phase 2 Study.
Hou X; Zhou C; Wu G; Lin W; Xie Z; Zhang H; Yi J; Peng Z; Yin L; Ma C; Chen L
J Thorac Oncol; 2023 Jun; 18(6):769-779. PubMed ID: 36738928
[TBL] [Abstract] [Full Text] [Related]
9. Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance.
Carney SV; Banerjee K; Mujeeb A; Zhu B; Haase S; Varela ML; Kadiyala P; Tronrud CE; Zhu Z; Mukherji D; Gorla P; Sun Y; Tagett R; Núñez FJ; Luo M; Luo W; Ljungman M; Liu Y; Xia Z; Schwendeman A; Qin T; Sartor MA; Costello JF; Cahill DP; Lowenstein PR; Castro MG
Clin Cancer Res; 2023 May; 29(9):1763-1782. PubMed ID: 36692427
[TBL] [Abstract] [Full Text] [Related]
10. Targeting brd4 and PI3K signaling pathways for the treatment of medulloblastoma.
Sethi B; Kumar V; Jayasinghe TD; Dong Y; Ronning DR; Zhong HA; Coulter DW; Mahato RI
J Control Release; 2023 Feb; 354():80-90. PubMed ID: 36599397
[TBL] [Abstract] [Full Text] [Related]
11. Preoperative Chemoradiotherapy With capecitabine With or Without Temozolomide in Patients With Locally Advanced Rectal cancer: A Prospective, Randomised Phase II Study Stratified by O
Oh CR; Kim JE; Lee JS; Kim SY; Kim TW; Choi J; Kim J; Park IJ; Lim SB; Park JH; Kim JH; Choi MK; Cha Y; Baek JY; Beom SH; Hong YS
Clin Oncol (R Coll Radiol); 2023 Feb; 35(2):e143-e152. PubMed ID: 36376167
[TBL] [Abstract] [Full Text] [Related]
12. A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Kling MJ; Kesherwani V; Mishra NK; Alexander G; McIntyre EM; Ray S; Challagundla KB; Joshi SS; Coulter DW; Chaturvedi NK
J Exp Clin Cancer Res; 2022 Nov; 41(1):321. PubMed ID: 36357906
[TBL] [Abstract] [Full Text] [Related]
13. Depression, Anxiety, and Their Association to Health-Related Quality of Life in Men Commencing Prostate cancer treatment at Tertiary Hospitals in cape Town, South Africa.
Irusen H; Fernandez P; Van der Merwe A; Suliman S; Esterhuizen T; Lazarus J; Parkes J; Seedat S
Cancer Control; 2022; 29():10732748221125561. PubMed ID: 36112984
[TBL] [Abstract] [Full Text] [Related]
14. DNA Mismatch Repair-deficient Rectal cancer Is Frequently Associated With Lynch Syndrome and With Poor Response to Neoadjuvant Therapy.
Farchoukh LF; Celebrezze J; Medich D; Cunningham K; Holder-Murray J; Holtzman M; Lee K; Choudry H; Pai RK
Am J Surg Pathol; 2022 Sep; 46(9):1260-1268. PubMed ID: 35551135
[TBL] [Abstract] [Full Text] [Related]
15. Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.
; Bradbury CA; Lawler PR; Stanworth SJ; McVerry BJ; McQuilten Z; Higgins AM; Mouncey PR; Al-Beidh F; Rowan KM; Berry LR; Lorenzi E; Zarychanski R; Arabi YM; Annane D; Beane A; van Bentum-Puijk W; Bhimani Z; Bihari S; Bonten MJM; Brunkhorst FM; Buzgau A; Buxton M; Carrier M; Cheng AC; Cove M; Detry MA; Estcourt LJ; Fitzgerald M; Girard TD; Goligher EC; Goossens H; Haniffa R; Hills T; Huang DT; Horvat CM; Hunt BJ; Ichihara N; Lamontagne F; Leavis HL; Linstrum KM; Litton E; Marshall JC; McAuley DF; McGlothlin A; McGuinness SP; Middeldorp S; Montgomery SK; Morpeth SC; Murthy S; Neal MD; Nichol AD; Parke RL; Parker JC; Reyes LF; Saito H; Santos MS; Saunders CT; Serpa-Neto A; Seymour CW; Shankar-Hari M; Singh V; Tolppa T; Turgeon AF; Turner AM; van de Veerdonk FL; Green C; Lewis RJ; Angus DC; McArthur CJ; Berry S; Derde LPG; Webb SA; Gordon AC
JAMA; 2022 Apr; 327(13):1247-1259. PubMed ID: 35315874
[TBL] [Abstract] [Full Text] [Related]
16. Synthesis, in vitro and structural aspects of cap substituted Suberoylanilide hydroxamic acid analogs as potential inducers of apoptosis in Glioblastoma cancer cells via HDAC /microRNA regulation.
Mekala JR; Ramalingam PS; Mathavan S; Yamajala RBRD; Moparthi NR; Kurappalli RK; Manyam RR
Chem Biol Interact; 2022 Apr; 357():109876. PubMed ID: 35283086
[TBL] [Abstract] [Full Text] [Related]
17. Chromatin Remodeling Induced by ARID1A Loss in Lung cancer Promotes Glycolysis and Confers JQ1 Vulnerability.
Liu X; Li Z; Wang Z; Liu F; Zhang L; Ke J; Xu X; Zhang Y; Yuan Y; Wei T; Shan Q; Chen Y; Huang W; Gao J; Wu N; Chen F; Sun L; Qiu Z; Deng Y; Wang X
Cancer Res; 2022 Mar; 82(5):791-804. PubMed ID: 34987057
[TBL] [Abstract] [Full Text] [Related]
18. Targeting Human Osteoarthritic Chondrocytes with Ligand Directed Bacteriophage-Based Particles.
Chongchai A; Waramit S; Wongwichai T; Kampangtip J; Phitak T; Kongtawelert P; Hajitou A; Suwan K; Pothacharoen P
Viruses; 2021 Nov; 13(12):. PubMed ID: 34960616
[TBL] [Abstract] [Full Text] [Related]
19. Are there predilection sites for intracranial meningioma? A population-based atlas.
Hosainey SAM; Bouget D; Reinertsen I; Sagberg LM; Torp SH; Jakola AS; Solheim O
Neurosurg Rev; 2022 Apr; 45(2):1543-1552. PubMed ID: 34674099
[TBL] [Abstract] [Full Text] [Related]
20. Downregulated CLIP3 induces radioresistance by enhancing stemness and glycolytic flux in glioblastoma.
Kang H; Lee S; Kim K; Jeon J; Kang SG; Youn H; Kim HY; Youn B
J Exp Clin Cancer Res; 2021 Sep; 40(1):282. PubMed ID: 34488821
[TBL] [Abstract] [Full Text] [Related]
[Next]
